The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost Data.

U Persson, M Willis, K Odegaard, Jan Apelqvist

Research output: Contribution to journalArticlepeer-review

38 Citations (SciVal)
Original languageEnglish
Pages (from-to)39-46
JournalValue in Health
Volume3 Suppl 1
Publication statusPublished - 2000

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Pediatrics/Urology/Gynecology/Endocrinology (013240400), Section I-II (013230011), Diabetes and Endocrinology (013241530)

Subject classification (UKÄ)

  • Health Care Service and Management, Health Policy and Services and Health Economy

Cite this